Investor mix
20 investors on record; lead investors include Vivo Capital; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 65% |
| Private equity | 4 | 20% |
| Angel & family office | 1 | 5% |
| Other / undisclosed | 2 | 10% |
Developer of targeted therapies to treat cancer
20 investors on record; lead investors include Vivo Capital; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 65% |
| Private equity | 4 | 20% |
| Angel & family office | 1 | 5% |
| Other / undisclosed | 2 | 10% |